Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Abstract

A study in evolution: that''s been the story of Serono International''s office of strategic management. Initially chartered with a limited mandate, it assumed a dramatically expanded role after a new chief executive officer took over. In the past 10 years, the office has played an integral part in the transformation of the Geneva-based biotechnology and pharmaceutical company from a relatively small, family-run, mainly national player to a US$2.5 billion global giant with eight manufacturing plants and 4,900 employees in 45 countries - the largest biotechnology company in Europe and third-largest worldwide.

About

Abstract

A study in evolution: that''s been the story of Serono International''s office of strategic management. Initially chartered with a limited mandate, it assumed a dramatically expanded role after a new chief executive officer took over. In the past 10 years, the office has played an integral part in the transformation of the Geneva-based biotechnology and pharmaceutical company from a relatively small, family-run, mainly national player to a US$2.5 billion global giant with eight manufacturing plants and 4,900 employees in 45 countries - the largest biotechnology company in Europe and third-largest worldwide.

Settings


Related